was read the article
array:19 [ "pii" => "X1665579614676064" "issn" => "16655796" "estado" => "S300" "fechaPublicacion" => "2014-10-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Medicina Universitaria. 2014;16:199-206" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4047 "formatos" => array:3 [ "EPUB" => 53 "HTML" => 3315 "PDF" => 679 ] ] "itemSiguiente" => array:15 [ "pii" => "X1665579614676072" "issn" => "16655796" "estado" => "S300" "fechaPublicacion" => "2014-10-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Medicina Universitaria. 2014;16:207-15" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3073 "formatos" => array:3 [ "EPUB" => 46 "HTML" => 2326 "PDF" => 701 ] ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Ebola virus disease 2014" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "207" "paginaFinal" => "215" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "304v16n65-90367607fig2.jpg" "Alto" => 2004 "Ancho" => 1491 "Tamanyo" => 567862 ] ] "descripcion" => array:1 [ "en" => "Algorithm for Evaluation of the Returned Traveler." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Kame Galán-Huerta, Daniel Arellanos-Soto, Ana María Rivas-Estilla, Verónica Bravo-de la Cruza, Javier Ramos-Jiménez" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Kame" "apellidos" => "Galán-Huerta" ] 1 => array:2 [ "nombre" => "Daniel" "apellidos" => "Arellanos-Soto" ] 2 => array:2 [ "nombre" => "Ana María" "apellidos" => "Rivas-Estilla" ] 3 => array:2 [ "nombre" => "Verónica" "apellidos" => "Bravo-de la Cruza" ] 4 => array:2 [ "nombre" => "Javier" "apellidos" => "Ramos-Jiménez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X1665579614676072?idApp=UINPBA00004N" "url" => "/16655796/0000001600000065/v0_201607061452/X1665579614676072/v0_201607061453/en/main.assets" ] "itemAnterior" => array:15 [ "pii" => "X1665579614676056" "issn" => "16655796" "estado" => "S300" "fechaPublicacion" => "2014-10-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Medicina Universitaria. 2014;16:184-98" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 10362 "formatos" => array:3 [ "EPUB" => 55 "HTML" => 9366 "PDF" => 941 ] ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Congenital vascular malformations update" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "184" "paginaFinal" => "198" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "304v16n65-90367605fig3.jpg" "Alto" => 1941 "Ancho" => 2104 "Tamanyo" => 341018 ] ] "descripcion" => array:1 [ "en" => "Klippel-Trenaunay syndrome. A: capillary malformation (port-wine stain: diffuse, irregular borders and dim color) on the lateral face of the thorax and abdomen, lymphatic cyst on the axillary region. B: scoliosis and capillary malformation on the back of the chest and abdomen. C: increase in the volume of the fingers secondary to lymphedema. D: hypertrophy and lymphedema of the lower extremities. E: venous malformation in the medial aspect of the upper third of the left leg. F: acute complication of lymphedema: onicocriptosis and cellulitis of the first toe." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Felipe G. Rendón-Elías, Marely Hernández-Sánchez, Rosemberg Albores-Figueroa, Fernando Félix Montes-Tapia, Luis Humberto Gómez-Danés" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Felipe G." "apellidos" => "Rendón-Elías" ] 1 => array:2 [ "nombre" => "Marely" "apellidos" => "Hernández-Sánchez" ] 2 => array:2 [ "nombre" => "Rosemberg" "apellidos" => "Albores-Figueroa" ] 3 => array:2 [ "nombre" => "Fernando Félix" "apellidos" => "Montes-Tapia" ] 4 => array:2 [ "nombre" => "Luis Humberto" "apellidos" => "Gómez-Danés" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X1665579614676056?idApp=UINPBA00004N" "url" => "/16655796/0000001600000065/v0_201607061452/X1665579614676056/v0_201607061453/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "titulo" => "Use of medications on the elderly" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "199" "paginaFinal" => "206" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Alejandra Lorena Tamez-Peña, Héctor Eloy Tamez-Pérez, Anamaría Peña-Lazo, Jorge Ocampo-Candiani, Juan Francisco Torres-Pérez" "autores" => array:5 [ 0 => array:3 [ "nombre" => "Alejandra Lorena" "apellidos" => "Tamez-Peña" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "nombre" => "Héctor Eloy" "apellidos" => "Tamez-Pérez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 2 => array:3 [ "nombre" => "Anamaría" "apellidos" => "Peña-Lazo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] ] ] 3 => array:3 [ "nombre" => "Jorge" "apellidos" => "Ocampo-Candiani" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 4 => array:3 [ "nombre" => "Juan Francisco" "apellidos" => "Torres-Pérez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Dermatology Services, Dr. José Eleuterio González University Hospital, Monterrey, Nuevo León, México" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Office of Research, School of Medicine, UANL, Monterrey, Nuevo León, México" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] 2 => array:3 [ "entidad" => "Dermatology, Private Practice, Monterrey, Nuevo León, México" "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] 3 => array:3 [ "entidad" => "Geriatrics Services, Dr. José Eleuterio González University Hospital, Monterrey, Nuevo León, México " "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] ] ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Introduction </span></p><p class="elsevierStylePara"> According to the World Health Organization (WHO), any individual who is more than 60 years old is considered elderly or an older person. This definition applies for most industrialized countries and the UN.<span class="elsevierStyleSup">1</span> The number of elderly is increasing worldwide with over 200 million older people, and an increase of 30% is expected in the next few years.<span class="elsevierStyleSup">1</span></p><p class="elsevierStylePara"> In Mexico, in 2010 the National Institute of Statistics and Geography (INEGI by its Spanish acronym) recorded over 11 million elderly in its census,<span class="elsevierStyleSup">2</span> and according to the projections by the National Population Council, by the year 2050 older people will represent 28% of the Mexican population, with approximately 36 million people.<span class="elsevierStyleSup">3</span> Nowadays, the elderly population is growing twice as fast as the country’s population growth rate.</p><p class="elsevierStylePara"> The increase in life expectancy has an impact in terms of health, which is reflected in a substantial increase in chronic degenerative diseases, thus making the technological and economic development that this epidemiologic transition requires necessary, with a demand for multidisciplinary medical strategies. Prescription and consumption of medications has increased among the geriatric population, hence the presence of adverse pharmacological events. The objective of this document is to make a brief review of the main physiological changes of the elderly, as well as summarizing the contribution of consensuses about prescriptions in this population.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Pharmacology in the elderly </span></p><p class="elsevierStylePara"> The elderly population presents physiological and pharmacologic changes which make it especially susceptible to presenting secondary or adverse events to medications, even with commonly used pharmaceutics.<span class="elsevierStyleSup">4,5</span> The need to know about prescriptions, clinic pharmacology and use of medication in the geriatric population becomes evident, in addition to preparing social, economic and health systems for current and future population demographic changes.<span class="elsevierStyleSup">6-8</span> It is estimated that people over 65 consume 25-50% of all prescribed pharmaceutics, and are responsible for 70% of the total pharmaceutical expenditure.<span class="elsevierStyleSup">9</span> Different studies have calculated that two thirds of geriatric patients receive an inappropriate dosage of medication, especially those with renal elimination.<span class="elsevierStyleSup">10-12</span> Moreover, the harmful effects of the pharmaceutics may have safety consequences and economically affect the health system.<span class="elsevierStyleSup">13</span></p><p class="elsevierStylePara"> Approximately 30% of hospital admissions of older patients is linked to the toxic effects of pharmaceutics. The related adverse effects of pharmaceutics have been associated with preventable problems, like depression, constipation, falls, immobility, confusion and hip injuries.<span class="elsevierStyleSup">13</span></p><p class="elsevierStylePara"> In a study conducted in patients who live in retirement homes, it was proved that approximately two thirds of residents had an ADR in a period of four years and out of them 1 in 7 required hospitalization.<span class="elsevierStyleSup">14</span> In the US in 2012 problems related to medications caused 106 000 deaths with a cost of 85 billion dollars. Other authors have calculated the ADR-related expenditure to be $76.6 billion in outpatient care, $20 billion in hospitals and $4 billion in nursing homes.<span class="elsevierStyleSup">13,15</span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">Physical changes in the elderly </span></p><p class="elsevierStylePara"> Physiologically, the elderly is in a state characterized by a reduction in functional reserves and their ability to adapt,<span class="elsevierStyleSup">6,16-18</span> which suggests a different response to that of a young patient when dealing with a disease or the administration of certain medication. Proper knowledge of the changes in pharmacokinetics and pharmacodynamics in the elderly is necessary for a correct prescription, which minimizes or avoids adverse effects of medications.<span class="elsevierStyleSup">6,18-20</span></p><p class="elsevierStylePara"> Variability in response to pharmacological intervention is conditioned by genetic factors, age, diseases, interactions and prescription compliance, which results in alterations in the pharmacokinetics and pharmacodynamics profiles, in addition to the frequent atypical presentations of diseases and the administration of multiple medications.<span class="elsevierStyleSup">21,22</span></p><p class="elsevierStylePara"> Pharmacokinetics</p><p class="elsevierStylePara"> Pharmacokinetics determine the relationship between a medication administration and the concentration which it reaches in the body with time (in relationship with the dosage, presentation, frequency and form of administration), and despite the fact that many changes of these parameters have been described, inter-individual variability is the rule.<span class="elsevierStyleSup">6,18,19</span></p><p class="elsevierStylePara"> Bioavailability refers to the proportion of the medication that reaches circulation, and it is a function of the form of administration, the chemical properties of the medication and the absorption and amount of dosage which is eliminated through the hepatic metabolism of the first step before reaching circulation.<span class="elsevierStyleSup">6,17</span> Bioavailability is affected by age, because absorption becomes slower, increasing the necessary time to reach maximum concentration in plasma. Some medications require an acid environment for its absorption, like ketoconazole, ampicillin or iron, and may have a decline of their bioavailability from 5 to 10%, as a result of hypochlorhydria secondary to atrophic gastritis or treatment with H<span class="elsevierStyleInf">2</span> antagonists and proton-bomb inhibitors.<span class="elsevierStyleSup">17-19</span> In the elderly, the hepatic metabolism of the first step is diminished, and oral medication bioavailability which goes through this process is greater.<span class="elsevierStyleSup">17,18</span></p><p class="elsevierStylePara"> Distribution volume depends on the plasma’s union to protein, on water and lipid proportion and on tissue perfusion. The latter may decrease with age, causing a slower distribution, and a reduction of the dosage load with most medications should be considered.<span class="elsevierStyleSup">17,18</span> Concerning water and lipids proportion, body fat in the elderly is considered to increase between 20 and 40% and corporal water decreases by 10 to 15%, leading to an increase in concentration of water-soluble medications and a slower elimination of fat-soluble medications.<span class="elsevierStyleSup">18-21</span></p><p class="elsevierStylePara"> Some medications which present a lower distribution volume in the elderly are digoxin, cimetidine, gentamicin, phenytoin and theophylline, among others, and this translates to high plasmatic levels of the medications.<span class="elsevierStyleSup">18</span></p><p class="elsevierStylePara"> The most important elimination mechanisms are hepatic and renal. Hepatic metabolism in older people has a substantial decrease in its activity and there are also changes in the gastrointestinal system, like a decrease in gastric acid secretion and intestinal motility.<span class="elsevierStyleSup">6,19</span> This decrease in elimination rate prolongs medications’ half-lives and carries with it the need to increase administration intervals.<span class="elsevierStyleSup">6,18</span> This occurs with medications like acetaminophen, amitriptyline, barbiturates, ibuprofen, lidocaine, prazosin, propranolol, salicilates and warfarin, among others.<span class="elsevierStyleSup">18 </span></p><p class="elsevierStylePara"> Pharmacodynamics</p><p class="elsevierStylePara"> Pharmacodynamics describes the effects of medications in tissue (what medications cause in the body).<span class="elsevierStyleSup">6-18</span> Although it can be altered by age, these changes have not been thoroughly studied. Almost every action of the medications are mediated by a interaction of medication molecules with tissue receptors, and these can be altered by hormones, neurotransmitters and transportation systems, among others, and the central nervous and cardiovascular systems play a very important role.<span class="elsevierStyleSup">6 </span></p><p class="elsevierStylePara"> Pharmacogenetics</p><p class="elsevierStylePara"> Genetic variation is one of the causes of versatility in responses to medications and is estimated to contribute between 20 and up to 95%, even though the genetic expression can also be related to age and environmental factors.<span class="elsevierStyleSup">6</span> The aging process itself and the presentation of diseases have polygenic causes, thus the response to many medications can also be altered by polymorphisms in genes that may not be responsible for the pharmacokinetic or are not its direct target.<span class="elsevierStyleSup">6</span> In table 1 there is a summary of the main physiological changes linked to age.</p><p class="elsevierStylePara"><img alt="Table 1 Principal physiological changes in the elderly" src="304v16n65-90367606fig1.jpg"></img></p><p class="elsevierStylePara"><span class="elsevierStyleBold">Adverse effects of the use of medications in geriatrics </span></p><p class="elsevierStylePara"> Prescription errors in the elderly population are generally related to pharmacological changes, inadequate orientation about dosage modification, and lack of recommendations or guides about safety of some medications in the geriatric population.<span class="elsevierStyleSup">21,22</span></p><p class="elsevierStylePara"> Sometimes, randomized and controlled studies do not include patients over 65 years, consequently the results on the safety of some medications cannot be generalized to this population. Adverse effects of medications include adverse reactions and prescription errors. An adverse medication reaction (AMR) is defined as any undesired sign or symptom which appears after medication administration at therapeutic doses. A severe or extremely severe AMR is one which requires hospitalization or causes irreversible damage including death.<span class="elsevierStyleSup">1,6,18</span> Adverse reactions are classified based on their relation with a medication in five groups (A-E). Type A is linked to the medication’s pharmacologic action, predictable or dosage-associated (pharmacokinetic changes, medication-medication, medication-food or medication-disease interactions), and represent most of the adverse effects. In group B there is no relation with pharmacologic actions and are independent of dosage, these are less frequent but more severe (allergic reactions, cytotoxic, idiosyncratic, etc.), and are unpredictable.<span class="elsevierStyleSup">22,23</span> The reactions of group C are related to prolonged and continuous use of a medication, such as dependency reactions or tachyphylaxis. Group D refers to late or long-term reactions like teratogenicity, and carcinogesis and group E is produced when a medication is suspended (“rebound effect”).</p><p class="elsevierStylePara"> However, there are many classification systems. Mallet et al suggest a simple approach to the problem, and summarizes it in three categories, which are adverse reactions by pharmacologic interactions; patients who consume multiple medications and/or have multiple diseases (nine or more medications and five or more comorbidities); and the “prescription cascade” phenomenon, where the adverse effect of a medication leads to the prescription of another agent which at the same time causes a new secondary effect which would add a new medication.<span class="elsevierStyleSup">23-25</span> Most adverse reactions to medications in hospitalized elderly are type A and therefore represent predictable reactions and are potentially preventable.<span class="elsevierStyleSup">26,27</span></p><p class="elsevierStylePara"> The medications that relate the most to adverse reactions and events are medications used to treat cardiovascular diseases, followed by rheumatologic and endocrinological medications, and this corresponds with the frequency and morbidity of these diseases in Mexico.<span class="elsevierStyleSup">27 </span></p><p class="elsevierStylePara"> Polypharmacy</p><p class="elsevierStylePara"> The use of concomitant medications is justified in the treatment of multiple chronic diseases. Polypharmacy is a term which describes patients who receive multiple medications, and in the elderly, this represents the rule rather than the exception.<span class="elsevierStyleSup">16,17</span></p><p class="elsevierStylePara"> According to data from population studies in the United States, 90% of the elderly consume at least a weekly medication, over 55% of women and 44% of men of advanced age consume five medications or more, and 40% of residents in nursing homes consume over eight weekly medications.<span class="elsevierStyleSup">4,5,16</span></p><p class="elsevierStylePara"> With this practice the risk of AMR increases drastically, because on many occasions, there are duplicates of the same kind of medication, and the adverse effects are not identified, leading to a prescription cascade.<span class="elsevierStyleSup">23-25,28</span></p><p class="elsevierStylePara"> Adverse reactions may be difficult to detect in elderly patients because they frequently have atypical presentations, like lethargy, confusion, falls, constipation and depression.</p><p class="elsevierStylePara"> Nursing homes residents are the most vulnerable of this group.<span class="elsevierStyleSup">28 </span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">An appropriate use of medications in geriatrics? </span></p><p class="elsevierStylePara"> With the purpose of minimizing the problems that emerge as a consequence of inappropriate prescription of medications in the elderly, consensus criteria have been developed in order to improve safety among this population.</p><p class="elsevierStylePara"> Beers criteria</p><p class="elsevierStylePara"> Beers et al,<span class="elsevierStyleSup">28</span> in 1999, supported by a group of experts in geriatrics, geriatric pharmacology, psychopharmacology and pharmacoepidemiology, in addition to the revision of scientific literature, developed a consensus of medications used in the elderly and their frequent adverse effects. Criterion were developed which have been widely used to describe treatment patterns and educate and inform clinical doctors. A revision of these criteria was made in 1997<span class="elsevierStyleSup">29</span> and later in 2003<span class="elsevierStyleSup">30</span> to reevaluate new products, to reassess the severity assigned to each medication and to identify new situations or major considerations. The application of these criteria have allowed an improvement of pharmacological therapy safety, since it identifies risk factors associated with prescription and suggests safety improvement programs.</p><p class="elsevierStylePara"> Beers’ criteria grouped medications into two groups; medications which should be avoided by the elderly because of their inefficacy or representation of an unnecessary risk, having other alternatives (table 2), and those medications which should not be used in the elderly even when they meet specific medical requirements (table 3). Moreover it stresses the importance of identifying prescription cascade.<span class="elsevierStyleSup">13</span></p><p class="elsevierStylePara"><img alt="Table 2 Medications specifically inappropriate for the elderly" src="304v16n65-90367606fig2.jpg"></img></p><p class="elsevierStylePara"><img alt="Table 3 Medications specifically inappropiate for the elderly by clinical diagnosis" src="304v16n65-90367606fig3.jpg"></img></p><p class="elsevierStylePara"> Medications mostly implicated in adverse events are cardiovascular, antibiotics, diuretics, anticoagulants, hypoglycemiants, steroids, opiates, anticholinergics, benzodiazepines and non-steroidal anti-inflammatory, among others.</p><p class="elsevierStylePara"> While Beers’ criteria is very useful, there are some limitations in their use. Some medications listed as inappropriate, may have acceptable applications; likewise, there are medications which are not included and may confer risk with their use.<span class="elsevierStyleSup">7,31,32</span></p><p class="elsevierStylePara"> The InterRAI Corporation is a network of researchers and clinics from 30 different countries around the world, and it has developed and standardized instruments for geriatric care currently being used in many countries. These instruments provide valid scales in geriatric patients, important in clinical practice, which may have a positive effect on individual care and treatment.<span class="elsevierStyleSup">7,33</span></p><p class="elsevierStylePara"> In 2009, Hanlon et al conducted a consensus in order to establish guidelines for the use of oral medications with renal elimination used in the elderly. The obtained results were in the form of two recommendations, medications which should be avoided in patients with a renal function of <30 mL/min like chlorpropamide, colchicine, cotrimoxazole, glyburide, meperidine, nitrofurantoin, probenecid, propoxyphene, spironolactone and triamterene; and those which require dosage reduction or a more ample administration interval, like acyclovir, amantadine, ciprofloxacin, gabapentin, memantine, ranitidine, rimantadine and valacyclovir. Frequently used medications which require renal adjustment can be found in table 4.</p><p class="elsevierStylePara"><img alt="Table 4 Commonly used medications that require renal adjustment" src="304v16n65-90367606fig4.jpg"></img></p><p class="elsevierStylePara"> Two identification tools to identify mistakes in prescriptions for the elderly were developed with the use of the English acronyms STOPP (screening tool of older persons’ prescription) and START (screening tool to alert to right treatment); identifying those medications which should be avoided, as well as those appropriate in the treatment of the elderly. The most commonly used medications are mentioned in tables 5 and 6.<span class="elsevierStyleSup">34</span> These studies proved that the potential omission of adequate medications in the elderly is as prevalent as the inclusion of inappropriate medications which should be avoided.<span class="elsevierStyleSup">5,34</span> A multidisciplinary team allows for a better quality in the attention of the elderly, and adequate prescriptions and an optimal control with a decrease of AMR.</p><p class="elsevierStylePara"><img alt="Table 5 Medications inappropriate for patients over 65 years, STOPP (Screening Tool of Older Persons Prescription)" src="304v16n65-90367606fig5.jpg"></img></p><p class="elsevierStylePara"><img alt="Table 6 Medications appropriate for patients over 65 years. START (Screening Tool to Alert to Right Treatment)" src="304v16n65-90367606fig6.jpg"></img></p><p class="elsevierStylePara"><span class="elsevierStyleBold">Education for prescriptions and general standards</span></p><p class="elsevierStylePara"> The challenge in prescribing medicine to the elderly</p><p class="elsevierStylePara"> The elderly have approximately 3 times more prescriptions than younger people. While the metabolism characteristics of geriatric patients which affect medication pharmacology are not modifiable, the choice of medication, length of the treatment and dosages are decisions which depend on the doctor, and are factors which can be optimized with the right knowledge and proper training in the treatment of geriatric patients.</p><p class="elsevierStylePara"> Every new medication must be evaluated in the following contexts: pharmacokinetic, pharmacodynamics and changes related to age regarding body composition and physiology.<span class="elsevierStyleSup">28</span></p><p class="elsevierStylePara"> While on occasion there are differences between geriatric guidelines and clinical practices from country to country, and the prescription is strongly influenced by feedback strategies and national forms, it is important to harmonize clinical and political recommendations as well as effective measures applied to our population in order to improve medical prescription.</p><p class="elsevierStylePara"> Planning of an integral systemic approach to the elderly and teaching strategies for continuous medical education, represent an essential component of a quality medical education.<span class="elsevierStyleSup">35-36</span> Some important points to consider, with the purpose of improving the quality of prescriptions in the geriatric population, are: to conduct an integral assessment of patients, in the medical, functional, mental and social aspects; to use medications of proven efficacy, known toxicity and with experience of use in the geriatric population, to periodically review medications prescribed by different doctors, including dosage and length; to avoid unnecessary medication; periodical monitoring and evaluation of therapeutic objectives and whether or not these are properly being met; prescribe medications with fewer adverse reactions and interactions; choose medications with easily recognizable presentations and administration intervals which allow for adequate compliance; search for the minimum effective dosage and increase progressively if necessary, as well as educate the patient and personnel responsible for their care on the proper administration, which avoids self-medication.<span class="elsevierStyleSup">8-9, 24, 35,36 </span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">Conclusions </span></p><p class="elsevierStylePara"> The elderly present physiological changes which affect the pharmacology of the medications used. Pharmacological studies cannot always extrapolate a medicine’s effect on the elderly, thus the most important challenge is to achieve optimal pharmacotherapy individualization.</p><p class="elsevierStylePara"> The application of consensus criteria during prescription helps the clinic in the decision-making process and functions as a tool to minimize problems associated with the use of medications. Prescription must be based on general standards or principles of the use of medications in the elderly, whose main objective is to decrease the use of multiple medications and increase safety and treatment adhesion.</p><p class="elsevierStylePara"> Physicians who attend the elderly should integrate their individual clinical experience with the best external evidence and comprehensible information in prognosis, limitations, preferences, family support and cost of treatment. A multidisciplinary approach and assistance coordination are indispensable in order to optimize this process.</p><hr></hr><p class="elsevierStylePara"> Received: November 2013; <br></br> Accepted: July 2014</p><p class="elsevierStylePara"> *Corresponding author: <br></br> Servicio de Dermatología, <br></br> Hospital Universitario “Dr. José Eleuterio González”, <br></br> de la Universidad Autónoma de Nuevo León, <br></br> Ave. Francisco I. Madero Pte. s/n y Ave. Gonzalitos, Col. Mitras Centro, <br></br> C.P. 64460 Monterrey, Nuevo León, México. <span class="elsevierStyleItalic"><br></br> E-mail address:</span><a href="mailto:lorale@hotmail.com" class="elsevierStyleCrossRefs">lorale@hotmail.com</a> (A.L. Tamez Peña).</p>" "pdfFichero" => "304v16n65a90367606pdf001.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec686844" "palabras" => array:3 [ 0 => "Elderly" 1 => "Adverse effect" 2 => "Medical prescription" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:1 [ "resumen" => "<p class="elsevierStylePara"> The elderly constitute a growing world population group, with more than 200 million people over 60 years of age. This fact has increased the detection of chronic-degenerative diseases, as well as the prescription and consumption of medicines. The elderly are particularly susceptible to adverse drug events or interactions with other drugs due to their physiological changes, genetic predisposition and environmental exposure. It becomes necessary to adapt the health systems with integral and multidisciplinary approaches suitable to this demographic change, as the knowledge about appropriate prescription, clinical pharmacology and medication use in the elderly has become essential.</p> <p class="elsevierStylePara"> It has been shown that about two thirds of elderly patients receive inappropriate drug doses, and a substantial percentage of their hospital admissions are associated with potentially preventable toxic effects of drugs. To date, expert criteria, error detection tools and educational prescription plans have been developed by expert consensus for the safe use of drugs in the geriatric population. The objective of this study is a brief review of the principal physiological changes in an older adult, and summarize the contributions of the consensuses on prescription.</p>" ] ] "multimedia" => array:12 [ 0 => array:8 [ "identificador" => "tbl1" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "304v16n65-90367606fig1.jpg" "imagenAlto" => 529 "imagenAncho" => 2091 "imagenTamanyo" => 152956 ] ] ] ] ] "descripcion" => array:1 [ "en" => "Principal physiological changes in the elderly" ] ] 1 => array:8 [ "identificador" => "tbl2" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "304v16n65-90367606fig2.jpg" "imagenAlto" => 1150 "imagenAncho" => 2104 "imagenTamanyo" => 295945 ] ] ] ] ] "descripcion" => array:1 [ "en" => "Medications specifically inappropriate for the elderly" ] ] 2 => array:8 [ "identificador" => "tbl3" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "304v16n65-90367606fig3.jpg" "imagenAlto" => 708 "imagenAncho" => 2095 "imagenTamanyo" => 179308 ] ] ] ] ] "descripcion" => array:1 [ "en" => "Medications specifically inappropiate for the elderly by clinical diagnosis" ] ] 3 => array:8 [ "identificador" => "tbl4" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "304v16n65-90367606fig4.jpg" "imagenAlto" => 1354 "imagenAncho" => 2083 "imagenTamanyo" => 216954 ] ] ] ] ] "descripcion" => array:1 [ "en" => "Commonly used medications that require renal adjustment" ] ] 4 => array:8 [ "identificador" => "tbl5" "etiqueta" => "Table 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "304v16n65-90367606fig5.jpg" "imagenAlto" => 2570 "imagenAncho" => 2104 "imagenTamanyo" => 679953 ] ] ] ] ] "descripcion" => array:1 [ "en" => "Medications inappropriate for patients over 65 years, STOPP (Screening Tool of Older Persons Prescription)" ] ] 5 => array:8 [ "identificador" => "tbl6" "etiqueta" => "Table 6" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "304v16n65-90367606fig6.jpg" "imagenAlto" => 1125 "imagenAncho" => 2104 "imagenTamanyo" => 309277 ] ] ] ] ] "descripcion" => array:1 [ "en" => "Medications appropriate for patients over 65 years. START (Screening Tool to Alert to Right Treatment)" ] ] 6 => array:7 [ "identificador" => "tbl7" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "descripcion" => array:1 [ "en" => "Principal physiological changes in the elderly" ] ] 7 => array:7 [ "identificador" => "tbl8" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "descripcion" => array:1 [ "en" => "Medications specifically inappropriate for the elderly" ] ] 8 => array:7 [ "identificador" => "tbl9" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "descripcion" => array:1 [ "en" => "Medications specifically inappropiate for the elderly by clinical diagnosis" ] ] 9 => array:7 [ "identificador" => "tbl10" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "descripcion" => array:1 [ "en" => "Commonly used medications that require renal adjustment" ] ] 10 => array:7 [ "identificador" => "tbl11" "etiqueta" => "Table 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "descripcion" => array:1 [ "en" => "Medications inappropriate for patients over 65 years, STOPP (Screening Tool of Older Persons Prescription)" ] ] 11 => array:7 [ "identificador" => "tbl12" "etiqueta" => "Table 6" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "descripcion" => array:1 [ "en" => "Medications appropriate for patients over 65 years. START (Screening Tool to Alert to Right Treatment)" ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:36 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Available from: http://www.who.int/es/. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Available from: http://www." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Organización Mundial de la Salud (OMS) [cited Aug 7" 1 => "2013]." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "who. " "fecha" => "int/es/" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Available from: http://www.inegi.org.mx/. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Available from: http://www.inegi." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "INEGI (Instituto Nacional de Estadística y Geografía) Censo Nacional de Población 2010 [cited Aug 15" 1 => "2013]." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "org. " "fecha" => "mx/" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "México. Proyecciones de Población 2000-2050 [cited Aug 15, 2013]. Available from: http://www.conapo.gob.mx/. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "México. Proyecciones de Población 2000-2050 [cited Aug 15, 2013]. Available from: http://www.conapo." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "CONAPO" 1 => "Consejo Nacional de Población." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "gob. " "fecha" => "mx/" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Polypharmacy and the geriatric patient. Clin Geriatr Med. 2007;23:371-90. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Polypharmacy and the geriatric patient." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Hayes BD" 1 => "Klein-Schwartz W" 2 => "Barrueto F Jr." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cger.2007.01.002" "Revista" => array:6 [ "tituloSerie" => "Clin Geriatr Med. " "fecha" => "2007" "volumen" => "23" "paginaInicial" => "371" "paginaFinal" => "90" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17462523" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287:337-44. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Kaufman DW" 1 => "Kelly JP" 2 => "Rosenberg L" 3 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "JAMA. " "fecha" => "2002" "volumen" => "287" "paginaInicial" => "337" "paginaFinal" => "44" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11790213" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "General principles of pharmacology. In: Halter J, Ouslander J, Tinetti M, Studenski S, High K, Asthana S, editors. Hazzards geriatric medicine and gerontology. 6th ed. New York: McGraw-Hill; 2009. p. 103-22. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "General principles of pharmacology. In: Halter J, Ouslander J, Tinetti M, Studenski S, High K, Asthana S, editors. Hazzards geriatric medicine and gerontology." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Hilmer SN" 1 => "Ford GA." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "6th ed. " "fecha" => "New York: McGraw-Hill" "volumen" => "2009. p. 103-22" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol. 2009;67:641-5. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Medication errors in elderly people: contributing factors and future perspectives." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Fialová D" 1 => "Onder T." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2125.2009.03419.x" "Revista" => array:6 [ "tituloSerie" => "Br J Clin Pharmacol. " "fecha" => "2009" "volumen" => "67" "paginaInicial" => "641" "paginaFinal" => "5" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19594531" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Cairo, 5-13 September 1994. ST/ESA/SER.A/149. Sales No. E.95.XIII.7. New York: United Nations Publications, 1999. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Cairo, 5-13 September 1994. ST/ESA/SER.A/149. Sales No. E.95.XIII." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Population and development: programme of action report of the International Conference on Population and Development." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "7. " "fecha" => "New York" "volumen" => "United Nations Publications, 1999" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Prescribing for older people. BMJ. 2008;336:606-9. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Prescribing for older people." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Milton JC" 1 => "Hill-Smith I" 2 => "Jackson SH." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.39503.424653.80" "Revista" => array:6 [ "tituloSerie" => "BMJ. " "fecha" => "2008" "volumen" => "336" "paginaInicial" => "606" "paginaFinal" => "9" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18340075" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Consensus guidelines for oral dosing of primarily renally cleared medications in older adults. J Am Geriatr Soc. 2009;57:335-40. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Consensus guidelines for oral dosing of primarily renally cleared medications in older adults." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Hanlon JT" 1 => "Aspinall SL" 2 => "Semla TP" 3 => "Weisbord SD" 4 => "Fried LF" 5 => "Buena CB" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1532-5415.2008.02098.x" "Revista" => array:6 [ "tituloSerie" => "J Am Geriatr Soc. " "fecha" => "2009" "volumen" => "57" "paginaInicial" => "335" "paginaFinal" => "40" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19170784" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "An analysis of discharge drug prescribing amongst elderly with renal impairment. Postgrad Med J. 1998;74:420-2. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "An analysis of discharge drug prescribing amongst elderly with renal impairment." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Wong NA" 1 => "Jones HW." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Postgrad Med J. " "fecha" => "1998" "volumen" => "74" "paginaInicial" => "420" "paginaFinal" => "2" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9799917" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Assessment of adherence to renal dosing guidelines in long-term care facilities. J Am Geriatr Soc. 2000;48:1470-3. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Assessment of adherence to renal dosing guidelines in long-term care facilities." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Papaioannou A" 1 => "Clarke JA" 2 => "Campbell T" 3 => "Bédard M." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Am Geriatr Soc. " "fecha" => "2000" "volumen" => "48" "paginaInicial" => "1470" "paginaFinal" => "3" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11083325" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-24. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Fick DM" 1 => "Cooper JW" 2 => "Wade WE" 3 => "Waller JL" 4 => "Maclean JR" 5 => "Beers MH." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archinte.163.22.2716" "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med. " "fecha" => "2003" "volumen" => "163" "paginaInicial" => "2716" "paginaFinal" => "24" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14662625" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study. South Med J. 1999;92:485-90. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Cooper JW." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "South Med J. " "fecha" => "1999" "volumen" => "92" "paginaInicial" => "485" "paginaFinal" => "90" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10342894" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "When medicine hurts instead of helps. Consultant Pharmacist. 1999;14:1326-30. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "When medicine hurts instead of helps." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Perry DP." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Consultant Pharmacist. " "fecha" => "1999" "volumen" => "14" "paginaInicial" => "1326" "paginaFinal" => "30" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Polypharmacy and the geriatric patient. Clin Geriatr Med. 2007;23:371-390, vii. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Polypharmacy and the geriatric patient." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Hayes BD" 1 => "Klein-Schwartz W" 2 => "Barrueto F Jr." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cger.2007.01.002" "Revista" => array:6 [ "tituloSerie" => "Clin Geriatr Med. " "fecha" => "2007" "volumen" => "23" "paginaInicial" => "371" "paginaFinal" => "390, vii" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17462523" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Inappropriate medications for elderly patients. Mayo Clin Proc. 2004;79:122-39. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Inappropriate medications for elderly patients." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Chutka DS" 1 => "Takahashi PY" 2 => "Hoel RW." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4065/79.1.122" "Revista" => array:6 [ "tituloSerie" => "Mayo Clin Proc. " "fecha" => "2004" "volumen" => "79" "paginaInicial" => "122" "paginaFinal" => "39" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14708956" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Duthie: Practice of Geriatrics. 4th ed. Philadelphia: Saunders; 2007. p. 17-32. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Duthie: Practice of Geriatrics." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Beyth RJ" 1 => "Shorr RI" 2 => "Duthie EH" 3 => "Kratz PR" 4 => "Malone M." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "4th ed. " "fecha" => "Philadelphia: Saunders" "volumen" => "2007. p. 17-32" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Pharmacokinetic and pharmacodynamic alterations in the geriatric patient. Consult Pharm. 2008;23:324-34. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Pharmacokinetic and pharmacodynamic alterations in the geriatric patient." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Delafuente JC." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Consult Pharm. " "fecha" => "2008" "volumen" => "23" "paginaInicial" => "324" "paginaFinal" => "34" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18454589" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother. 2007;5:263-303. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Pharmacodynamics in older adults: a review." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Bowie MW" 1 => "Slattum PW." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjopharm.2007.10.001" "Revista" => array:6 [ "tituloSerie" => "Am J Geriatr Pharmacother. " "fecha" => "2007" "volumen" => "5" "paginaInicial" => "263" "paginaFinal" => "303" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17996666" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem. 2010;17:571-84. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Corsonello A" 1 => "Pedone C" 2 => "Incalzi RA." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Curr Med Chem. " "fecha" => "2010" "volumen" => "17" "paginaInicial" => "571" "paginaFinal" => "84" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20015034" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "The challenge of managing drug interactions in elderly people. Lancet. 2007;370:185-91. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "The challenge of managing drug interactions in elderly people." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Mallet L" 1 => "Spinewine A" 2 => "Huang A." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(07)61092-7" "Revista" => array:6 [ "tituloSerie" => "Lancet. " "fecha" => "2007" "volumen" => "370" "paginaInicial" => "185" "paginaFinal" => "91" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17630042" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289:1652-8. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Drug-drug interactions among elderly patients hospitalized for drug toxicity." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Juurlink DN" 1 => "Mamdani M" 2 => "Kopp A" 3 => "Laupacis A" 4 => "Redelmeier DA." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.289.13.1652" "Revista" => array:6 [ "tituloSerie" => "JAMA. " "fecha" => "2003" "volumen" => "289" "paginaInicial" => "1652" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12672733" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Drug therapy. Lancet. 1995;346:32-6. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Drug therapy." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Rochon PA" 1 => "Gurwitz JH." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet. " "fecha" => "1995" "volumen" => "346" "paginaInicial" => "32" "paginaFinal" => "6" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7603146" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315:1096-9. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Optimising drug treatment for elderly people: the prescribing cascade." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Rochon PA" 1 => "Gurwitz JH." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ. " "fecha" => "1997" "volumen" => "315" "paginaInicial" => "1096" "paginaFinal" => "9" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9366745" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Reacciones adversas a medicamentos de pronóstico grave en ancianos institucionalizados. Rev Esp Geriatr Gerontol. 2003;38:193-7. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Reacciones adversas a medicamentos de pronóstico grave en ancianos institucionalizados." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Puchea E" 1 => "Lunab JD" 2 => "García J" 3 => "Góngora L." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Esp Geriatr Gerontol. " "fecha" => "2003" "volumen" => "38" "paginaInicial" => "193" "paginaFinal" => "7" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31:199-205. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Adverse drug events as a cause of hospital admission in the elderly." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Chan M" 1 => "Nicklason F" 2 => "Vial JH." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Intern Med J. " "fecha" => "2001" "volumen" => "31" "paginaInicial" => "199" "paginaFinal" => "205" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11456032" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Inappropriate prescribing in the elderly. Clin Pharm Ther. 2007;32:113-21. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Inappropriate prescribing in the elderly." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Gallagher P" 1 => "Barry P" 2 => "OMahony DJ." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Pharm Ther. " "fecha" => "2007" "volumen" => "32" "paginaInicial" => "113" "paginaFinal" => "21" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825-32. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Explicit criteria for determining inappropriate medication use in nursing home residents." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Beers MH" 1 => "Ouslander JG" 2 => "Rollingher J" 3 => "Reuben DB" 4 => "Beck JC." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med. " "fecha" => "1991" "volumen" => "151" "paginaInicial" => "1825" "paginaFinal" => "32" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1888249" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib30" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med. 1997;157:1531-6. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Explicit criteria for determining potentially inappropriate medication use by the elderly." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Beers MH." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med. " "fecha" => "1997" "volumen" => "157" "paginaInicial" => "1531" "paginaFinal" => "6" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9236554" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib31" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "A composite screening tool for medication reviews of outpatients: general issues with specific examples. Drugs Aging 2007;24:733-60. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "A composite screening tool for medication reviews of outpatients: general issues with specific examples." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "De Smet PA" 1 => "Denneboom W" 2 => "Kramers C" 3 => "Grol R." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "fecha" => "Drugs Aging 2007" "volumen" => "24" "paginaInicial" => "733" "paginaFinal" => "60" ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib32" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "STOPP (Screening Tool of Older Persons potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers criteria. Age Ageing. 2008;37:673-9. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "STOPP (Screening Tool of Older Persons potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers criteria." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Gallagher P" 1 => "OMahony D." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ageing/afn197" "Revista" => array:6 [ "tituloSerie" => "Age Ageing. " "fecha" => "2008" "volumen" => "37" "paginaInicial" => "673" "paginaFinal" => "9" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18829684" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib33" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system. BMC Health Serv Res. 2008;8:277. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Hirdes JP" 1 => "Ljunggren G" 2 => "Morris JN" 3 => "Frijters DH" 4 => "FinneSoveri H" 5 => "Gray L" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1472-6963-8-277" "Revista" => array:5 [ "tituloSerie" => "BMC Health Serv Res. " "fecha" => "2008" "volumen" => "8" "paginaInicial" => "277" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19115991" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib34" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med. 2010;1:45-51. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "OMahony D" 1 => "Gallagher P" 2 => "Ryan C" 3 => "Byrne S" 4 => "Hamilton H" 5 => "Barry P" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Eur Geriatr Med. " "fecha" => "2010" "volumen" => "1" "paginaInicial" => "45" "paginaFinal" => "51" ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib35" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Geriatric pharmacy education: a strategic plan for the future. Am J Pharm Educ. 2007;71:47. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Geriatric pharmacy education: a strategic plan for the future." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Odegard PS" 1 => "Breslow RM" 2 => "Koronkowski MJ" 3 => "Williams BR" 4 => "Hudgins GA." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Pharm Educ. " "fecha" => "2007" "volumen" => "71" "paginaInicial" => "47" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17619647" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib36" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "[Clinical practice guideline. Drug prescription in elderly]. Rev Med Inst Mex Seguro Soc. 2013;51:228-39. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "[Clinical practice guideline. Drug prescription in elderly]." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Peralta-Pedrero ML" 1 => "Valdivia-Ibarra FJ" 2 => "Hernández-Manzano M" 3 => "Medina-Beltrán GR" 4 => "Cordero-Guillén MA" 5 => "Baca-Zúñiga J" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Med Inst Mex Seguro Soc. " "fecha" => "2013" "volumen" => "51" "paginaInicial" => "228" "paginaFinal" => "39" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23693115" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16655796/0000001600000065/v0_201607061452/X1665579614676064/v0_201607061453/en/main.assets" "Apartado" => array:4 [ "identificador" => "55398" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Review articles" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/16655796/0000001600000065/v0_201607061452/X1665579614676064/v0_201607061453/en/304v16n65a90367606pdf001.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X1665579614676064?idApp=UINPBA00004N" ]
Original language: English
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 69 | 12 | 81 |
2024 October | 521 | 129 | 650 |
2024 September | 479 | 65 | 544 |
2024 August | 442 | 52 | 494 |
2024 July | 419 | 62 | 481 |
2024 June | 449 | 64 | 513 |
2024 May | 641 | 110 | 751 |
2024 April | 961 | 109 | 1070 |
2024 March | 736 | 92 | 828 |
2024 February | 518 | 40 | 558 |
2024 January | 531 | 64 | 595 |
2023 December | 606 | 161 | 767 |
2023 November | 596 | 136 | 732 |
2023 October | 717 | 180 | 897 |
2023 September | 437 | 83 | 520 |
2023 August | 299 | 46 | 345 |
2023 July | 282 | 41 | 323 |
2023 June | 299 | 79 | 378 |
2023 May | 406 | 71 | 477 |
2023 April | 312 | 69 | 381 |
2023 March | 300 | 84 | 384 |
2023 February | 185 | 42 | 227 |
2023 January | 232 | 86 | 318 |
2022 December | 298 | 50 | 348 |
2022 November | 439 | 82 | 521 |
2022 October | 300 | 53 | 353 |
2022 September | 266 | 56 | 322 |
2022 August | 154 | 37 | 191 |
2022 July | 178 | 35 | 213 |
2022 June | 211 | 31 | 242 |
2022 May | 269 | 41 | 310 |
2022 April | 297 | 69 | 366 |
2022 March | 266 | 52 | 318 |
2022 February | 242 | 66 | 308 |
2022 January | 239 | 34 | 273 |
2021 December | 179 | 48 | 227 |
2021 November | 320 | 82 | 402 |
2021 October | 188 | 27 | 215 |
2021 September | 159 | 32 | 191 |
2021 August | 165 | 35 | 200 |
2021 July | 130 | 28 | 158 |
2021 June | 159 | 30 | 189 |
2021 May | 343 | 52 | 395 |
2021 April | 789 | 99 | 888 |
2021 March | 431 | 40 | 471 |
2021 February | 301 | 44 | 345 |
2021 January | 361 | 43 | 404 |
2020 December | 249 | 44 | 293 |
2020 November | 309 | 57 | 366 |
2020 October | 195 | 34 | 229 |
2020 September | 265 | 34 | 299 |
2020 August | 217 | 38 | 255 |
2020 July | 269 | 30 | 299 |
2020 June | 289 | 59 | 348 |
2020 May | 302 | 43 | 345 |
2020 April | 308 | 54 | 362 |
2020 March | 240 | 21 | 261 |
2020 February | 205 | 23 | 228 |
2020 January | 132 | 15 | 147 |
2019 December | 99 | 20 | 119 |
2019 November | 110 | 14 | 124 |
2019 October | 98 | 13 | 111 |
2019 September | 89 | 12 | 101 |
2019 August | 88 | 6 | 94 |
2019 July | 81 | 17 | 98 |
2019 June | 100 | 27 | 127 |
2019 May | 133 | 35 | 168 |
2019 April | 73 | 31 | 104 |
2019 March | 54 | 10 | 64 |
2019 February | 35 | 18 | 53 |
2019 January | 44 | 4 | 48 |
2018 December | 14 | 7 | 21 |
2018 November | 27 | 5 | 32 |
2018 October | 88 | 5 | 93 |
2018 September | 91 | 7 | 98 |
2018 August | 31 | 2 | 33 |
2018 July | 33 | 1 | 34 |
2018 June | 21 | 2 | 23 |
2018 May | 47 | 6 | 53 |
2018 April | 43 | 1 | 44 |
2018 March | 25 | 0 | 25 |
2018 February | 17 | 0 | 17 |
2018 January | 14 | 2 | 16 |
2017 December | 9 | 0 | 9 |
2017 November | 22 | 1 | 23 |
2017 October | 27 | 0 | 27 |
2017 September | 7 | 1 | 8 |
2017 August | 14 | 4 | 18 |
2017 July | 20 | 2 | 22 |
2017 June | 16 | 8 | 24 |
2017 May | 27 | 9 | 36 |
2017 April | 15 | 5 | 20 |
2017 March | 13 | 24 | 37 |
2017 February | 26 | 1 | 27 |
2017 January | 9 | 1 | 10 |
2016 December | 17 | 0 | 17 |
2016 November | 25 | 8 | 33 |
2016 October | 28 | 1 | 29 |
2016 September | 8 | 0 | 8 |
2016 August | 15 | 4 | 19 |
2016 July | 20 | 2 | 22 |
2016 June | 83 | 11 | 94 |
2016 May | 70 | 18 | 88 |
2016 April | 58 | 28 | 86 |
2016 March | 51 | 17 | 68 |
2016 February | 57 | 16 | 73 |
2016 January | 48 | 21 | 69 |
2015 December | 52 | 12 | 64 |
2015 November | 54 | 15 | 69 |
2015 October | 65 | 16 | 81 |
2015 September | 58 | 13 | 71 |
2015 August | 71 | 15 | 86 |
2015 July | 109 | 10 | 119 |
2015 June | 57 | 14 | 71 |
2015 May | 98 | 41 | 139 |
2015 April | 75 | 18 | 93 |
2015 March | 90 | 14 | 104 |
2015 February | 70 | 24 | 94 |
2015 January | 75 | 18 | 93 |
2014 December | 45 | 12 | 57 |